[Sepsis and multiple organ failure - update of current therapeutic concepts].

No abstract is available for this paper.

• Publication year

  2005

• Venue

  AINS. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmertztherapie

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2005-870104PMID 16145638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early goal-directed therapy in the treatment of severe sepsis and septic shock.

  2018cited by this paper
• The surgical treatment of infective endocarditis

  2005cited by this paper
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  2004cited by this paper
• Infection and inflammation and the coagulation system.

  2003cited by this paper
• Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis

  2003cited by this paper
• Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

  2003cited by this paper
• Nutritional support in sepsis and multiple organ failure.

  2003cited by this paper
• [Clinical management of patients with sepsis].

  2003cited by this paper
• Adrenal function during coronary artery bypass grafting.

  2003cited by this paper
• Standards in der Diagnostik und Therapie der Sepsis

  2003cited by this paper
• Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

  2003cited by this paper
• Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium

  2002cited by this paper
• Coagulation inhibitors in the treatment of sepsis

  2002cited by this paper
• Assessing the use of activated protein C in the treatment of severe sepsis.

  2002cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Meta-analysis of hemodynamic optimization in high-risk patients*

  2002cited by this paper
• Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

  2001cited by this paper
• Effect of prone positioning on the survival of patients with acute respiratory failure.

  2001cited by this paper
• Stress-induced hyperglycemia.

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

  2001cited by this paper
• Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

  2001cited by this paper
• Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties.

  2001cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• Continuous versus intermittent renal replacement therapy: a meta-analysis

  2001cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients

  2001cited by this paper
• Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

  2000cited by this paper
• Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

  2000cited by this paper
• A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

  2000cited by this paper
• The biology of the receptor for advanced glycation end products and its ligands.

  2000cited by this paper
• Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.

  2000cited by this paper
• [Catecholamine therapy in sepsis] .

  2000cited by this paper
• A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

  1999cited by this paper
• Immune dysfunction in patients with diabetes mellitus (DM).

  1999cited by this paper
• Treating patients with severe sepsis.

  1999cited by this paper
• Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

  1999cited by this paper
• Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

  1999cited by this paper
• Insulin infusion improves neutrophil function in diabetic cardiac surgery patients.

  1999cited by this paper
• Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units.

  1998cited by this paper
• Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

  1998cited by this paper
• Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

  1998cited by this paper
• Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients.

  1997cited by this paper
• Clinical and bacteriological characteristics of infective endocarditis in the elderly.

  1997cited by this paper
• The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.

  1997cited by this paper
• Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations.

  1996cited by this paper
• The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients.

  1996cited by this paper
• Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

  1996cited by this paper
• Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association.

  1995cited by this paper
• Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

  1995cited by this paper
• Steroid controversy in sepsis and septic shock: a meta-analysis.

  1995cited by this paper
• Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.

  1994cited by this paper
• Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction.

  1994cited by this paper
• Open up the lung and keep the lung open

  1992cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Geriatric endocarditis: avoiding the trend toward mismanagement.

  1991cited by this paper
• Complications of coronary artery surgery in diabetic patients.

  1991cited by this paper
• Hospital-acquired infective endocarditis.

  1988cited by this paper
• Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

  1987cited by this paper

• Blood Glucose Variability as a Predictor of Mortality for Septic Patients in Intensive Care Unit

  2022cites this paper
• Comments on Xuebijing in the treatment of patients with sepsis: A meta-analysis.

  2019cites this paper
• Evaluierung der Erregeridentifizierung mittels Dialysefilter zur mikrobiologischen Diagnoseverbesserung bei Sepsis

  2017cites this paper
• Organisms cultured and resistance patterns seen in a secondary referral centre ICU and burns unit

  2015cites this paper
• Auswirkung von niedrig dosiertem Hydrokortison auf die Gerinnungsparameter bei Patienten im septischen Schock

  2013cites this paper
• ATIII attenuates endotoxemia induced healing impairment in the colon.

  2009cites this paper
• The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability

  2008cites this paper
• Microcirculatory dysfunction in endotoxemic bowel anastomosis: the pathogenetic contribution of microcirculatory dysfunction to endotoxemia-induced healing impairment.

  2008cites this paper